CRBP
CRBP
NASDAQ · Biotechnology

Corbus Pharmaceuticals Holdi

$2.75
-0.27 (-8.80%)
As of Nov 19, 1:25 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +342.6% upside
Low Target $8.71
Average Target $12.15
High Target $17.60
Current Price $2.75
Current
$2.75
Target
$12.15
$8.71 $12.15 avg $17.60
Scenario Analysis
Bear Case
$8.71
217.3%
Low target
Base Case
$12.15
+342.6%
Avg target
Bull Case
$17.60
+541.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$12.88
-78.7% from high
52-Week Low
$2.81
+-2.3% from low
Target vs 52W High
$12.15
-5.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -9.2%
AMGN
Amgen Inc
Hold 42 43% $190.87 -56.5%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +117.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -15.8%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.7%
MRNA
Moderna Inc
Hold 31 32% $149.45 -25.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -28.4%